Pan Cancer T

📍 Rotterdam, Netherlands🗓 Founded 2020👥 8 employees💰 Last funded Feb 2021
Biotechnology Research🌐 pancancer-t.com
Website LinkedIn
Pan Cancer T is a biotechnology spin-out (Erasmus MC, Rotterdam) focussed on the discovery and development of T cell receptor (TCR) T cell therapies. We exploit the 20 years of pioneering in adoptive T cell therapy as a springboard to breakthrough treatment of solid tumors. Pan Cancer T develops natural affinity TCR T cell therapies towards unique and proprietary intracellular targets expressed by multiple solid tumors, and make T cell therapy maximally accessible despite the tumor micro-environment challenges.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Netherlands
1
Frequently asked questions
Who invested in Pan Cancer T?
Pan Cancer T has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Pan Cancer T last raise funding?
The most recent investment in Pan Cancer T recorded on gritt.io was in February 2021.
When was Pan Cancer T founded?
Pan Cancer T was founded in 2020.
What industry is Pan Cancer T in?
Pan Cancer T operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Pan Cancer T based?
Pan Cancer T is headquartered in Rotterdam, Netherlands.